Bee sting case management from emergency to ipd to on discharge
bee sting envenomation emergency management anaphylaxis treatment
hymenoptera sting inpatient management complications monitoring
bee sting discharge planning venom immunotherapy follow-up allergist referral
massive bee sting toxic envenomation rhabdomyolysis renal failure treatment
| Category | Features | Urgency |
|---|---|---|
| Local reaction | Pain, erythema, swelling <10 cm at sting site | Routine |
| Large local reaction (LLR) | Swelling >10 cm, extending beyond joint, lasting >24 h | Urgent |
| Systemic / Anaphylaxis | Urticaria, angioedema, bronchospasm, hypotension, GI symptoms | Immediate — life-threatening |
| Toxic envenomation | Multiple stings (>50–100), haemolysis, rhabdomyolysis, coagulopathy | Resuscitation bay |
| Serum tryptase | Elevated early tryptase confirms mast cell activation / anaphylaxis | Send at 1–3 h post-event |
Serum tryptase measured early in the reaction provides evidence of anaphylaxis if levels are elevated or significantly increased from basal level (Stinging Insect Hypersensitivity, p. 13).
| Drug | Dose | Route | Indication |
|---|---|---|---|
| Epinephrine IV infusion | 0.1–1 mcg/kg/min | IV | Refractory shock/anaphylaxis not responding to IM |
| Salbutamol (nebulised) | 2.5–5 mg | Nebuliser | Bronchospasm |
| Chlorpheniramine | 10 mg | IM/slow IV | H1 antihistamine (adjunct — not first-line) |
| Ranitidine/Famotidine | 50 mg / 20 mg | IV | H2 antihistamine (adjunct) |
| Hydrocortisone | 200 mg | IV | Prevent biphasic reaction (adjunct) |
| Glucagon | 1–2 mg IV then infusion | IV | Anaphylaxis in beta-blocker patients |
IV epinephrine and other vasopressors, intubation/supplemental oxygen, fluid resuscitation, bronchodilators, and parenteral antihistamines are the mainstay of profound shock management (Harrison's, p. 13104).
| Parameter | Frequency |
|---|---|
| Vitals (BP, HR, SpO₂, RR) | Every 15 min × 1 h, then every 30 min × 2 h |
| Urine output | Hourly (catheterise if haemodynamically unstable) |
| Serum tryptase | At 1–3 h post-sting (send even if improving) |
| ECG | At presentation, repeat if abnormal |
Patients should be observed for 24 h for recurrent anaphylaxis, renal failure, or coagulopathy (Harrison's, p. 13104).
| Investigation | At Admission | 12–24 h | 48 h |
|---|---|---|---|
| CBC | ✓ | ✓ | If abnormal |
| LFT / RFT | ✓ | ✓ | ✓ |
| Serum CPK (CK) | ✓ | ✓ (if elevated) | Track to normalisation |
| Urinalysis (myoglobin/haemoglobin) | ✓ | ✓ | If abnormal |
| Coagulation (PT, aPTT, fibrinogen) | ✓ | ✓ if abnormal | |
| ECG | ✓ | Repeat if arrhythmia | |
| Serum tryptase (baseline) | Send at 24–48 h for baseline comparison |
| Complication | Management |
|---|---|
| AKI / Myoglobinuria | Aggressive IV hydration, urinary alkalinisation, avoid nephrotoxins, nephrology consult |
| Rhabdomyolysis | IV fluids targeting UO ≥1–2 mL/kg/h, monitor CK daily |
| Haemolysis | Monitor Hb, haematocrit; transfuse if symptomatic anaemia |
| Hepatic injury | LFT monitoring, avoid hepatotoxic drugs |
| Coagulopathy / DIC | FFP, platelets, vitamin K as indicated |
| Arrhythmia | Cardiology consult, continuous telemetry |
| Serum sickness (7–14 days) | Oral prednisolone, antihistamines |
| Medication | Dose/Duration | Purpose |
|---|---|---|
| Oral prednisolone | 0.5–1 mg/kg/day × 3–5 days (taper) | Prevent late-phase / serum sickness |
| Cetirizine or loratadine | 10 mg OD × 7 days | Antihistamine cover |
| Epinephrine auto-injector (EpiPen) | 0.3 mg × 2 devices | Emergency self-treatment if re-sting |
| MedicAlert bracelet | — | Identification of allergy in emergencies |
| Timing | Action |
|---|---|
| 24–72 h | GP review — wound check, medication tolerance, labs if applicable |
| 2–4 weeks | Allergist / Immunologist referral — mandatory after systemic anaphylaxis |
| At allergist | Skin prick test + intradermal testing for Hymenoptera venom |
| If eligible | Commence Venom Immunotherapy (VIT) |
BEE STING
│
▼
Classify Reaction
├── Local only ──► Analgesia, antihistamine, observe 30 min, discharge
├── Large local ──► Antihistamine + corticosteroid, observe 4–6 h, discharge with EpiPen
│
└── Systemic / Anaphylaxis / Toxic
│
▼
EMERGENCY
IM Epinephrine → Fluids → O₂ → Adjuncts → Observe 24 h
│
▼
ADMIT (IPD) if criteria met
Monitoring + IV corticosteroids + Organ support
│
▼
DISCHARGE when stable
EpiPen × 2 + Prednisolone taper + Antihistamine
Allergist referral → Venom Immunotherapy